Abbott Ultane “Dear Doctor” letter
Executive Summary
Abbott notifies clinicians of "rare, isolated reports of fire or extreme heat in the respiratory circuit of anesthesia machines when Ultane (sevoflurane) is used in conjunction with a desiccated CO2 absorbent." A Nov. 17 "Dear Doctor" adds that "ongoing investigations have not yet identified the exact etiology"...
You may also be interested in...
Argenx’s Autoimmune Disease Blockbuster-In-Waiting Gets FDA Decision Date
The Belgium-Netherlands based company looks on course to gain US approval by the end of 2021.
Device Week, 05 March - Remote Monitoring Reimbursement, T-cell Diagnostics And A Digital Health Feature
In this week's podcast, managing editor Marion Webb discusses a new monthly digital health roundup which will soon feature on Medtech Insight. Managing editor Reed Miller discusses reimbursement difficulties as it applies to remote cardiac monitoring. UK-based reporter Barnaby Pickering gives an overview of an interview with the chief medical officer of Adaptive Biotechnologies about its new T-Detect platform.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: